Investment
Features
FeesSafety
Academy
More
Pluang+

Dana Inc. to release Q3 2026 earnings on Oct 28 with a conference call and webcast.

Company Fundamentals
07 Oct 2026
PRNewsWire
View Source
Neutral
Dana Inc. to release Q3 2026 earnings on Oct 28 with a conference call and webcast.

Dana Incorporated will announce its third-quarter 2026 financial results on October 28, 2026. The company will issue a press release at 7 a.m. EDT, followed by a conference call and webcast at 9 a.m. EDT where senior management will discuss the results and answer questions. Dana is a global leader in vehicle propulsion solutions, serving light and commercial vehicle markets, and reported $7.5 billion in sales in 2025. Investors can access the call via phone or online through Dana's investor website, with a replay available after the event.

Dana Incorporated's upcoming third-quarter 2026 financial results are set for October 28, 2026. For readers following the Industrials sector, here is Pluang's market snapshot as of Oct 07, 2026 21:22 WIB: out of 93 priced US Industrials stocks, 15 rose and 78 fell. Notable movers include LUNR (Intuitive Machines) at USD 14.29 with a 1-day change of -5.15%, RDW (Redwire Corporation) at USD 10.08 down 5.08%, and VRT (Vertiv Holdings Co) at USD 240.49 down 5.00%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App